Clin2
NCT06959485Possibly a fitNot yet recruiting

Oxygen therapy for diabetic kidney disease

Diabetic Kidney Disease

Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.

This trial tests whether oxygen therapy can help people with diabetic kidney disease. It aims to see if extra oxygen can improve kidney function and reduce protein in urine.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
80 people
Ages
10 years to 17 years
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have diabetes and diabetic kidney disease.
  • Your kidney function (eGFR) should be between 30 and 90 mL/min/1.73m2.
  • You must have protein in your urine (more than 300 mg per day).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06846034Recruiting
How low oxygen affects kidney blood flow

This study tests how low oxygen levels affect blood flow in the kidneys. It includes healthy people, people with type 2 diabetes, and those with diabetes plus kidney disease to see if their kidneys respond differently.

Poitiers
NCT07022418Recruiting· Phase 2
Formoterol for diabetic kidney disease

This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.

Charleston, South Carolina
NCT07352436Not yet recruiting
Gut bacteria and blood markers in diabetic kidney disease

This study looks at how the bacteria in your gut and certain substances in your blood might affect blood sugar changes and kidney health in people with diabetic kidney disease. If you have type 2 diabetes and kidney issues, this trial could help find better ways to track your condition.

NCT06600412Recruiting· Phase 2
Testing R3R01 for protein in urine from diabetic kidney disease

This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.

Copenhagen, Copenhagen
NCT05888909Recruiting
Tests better diagnosis and treatment planning for kidney disease in type 2 diabetes

This trial focuses on improving how kidney damage is diagnosed and how treatment is planned for people with type 2 diabetes and kidney disease. It may help by using detailed medical history and (if done) kidney biopsy results to guide care more accurately.

Beijing
NCT06101901Not yet recruiting
Study on engagement among diabetic kidney disease patients

This study looks at how people with diabetic kidney disease participate in their own care. It aims to understand what helps or hinders engagement, which could lead to better support for patients.

San Francisco, California

Hear when a new Diabetic Kidney Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.